Delota Corp. (CSE:NIC)

Oncternal Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Cash & Equivalents	2.93	2.31	1.75	1.27	1.01
Cash & Short-Term Investments	2.93	2.31	1.75	1.27	1.01
Cash Growth	26.83%	31.94%	37.90%	25.85%	238.75%
Accounts Receivable	1.52	1.71	1.54	1.62	0.83
Receivables	1.52	1.71	1.54	1.62	0.83
Inventory	3.11	3.16	2.51	1.83	1.47
Prepaid Expenses	0.3	0.27	0.21	0.27	0.2
Total Current Assets	7.87	7.45	6.01	5	3.5
Property, Plant & Equipment	3.9	3.83	4.13	6.25	6.07
Other Intangible Assets	3.13	3.18	3.33	3.54	3.83
Long-Term Accounts Receivable	0.33	0.34	0.26	-	-
Total Assets	15.22	14.8	13.74	14.78	13.41
Accounts Payable	2.97	2.85	3.74	3.3	2.08
Accrued Expenses	2.49	2.25	0.89	1.09	0.45
Short-Term Debt	0.45	0.45	0.55	0.63	11.86
Current Portion of Long-Term Debt	1.07	0.97	0.24	0.18	0.02
Current Portion of Leases	1.26	1.2	1.06	1.21	0.59
Current Unearned Revenue	0.39	0.41	0.31	0.13	0.11
Other Current Liabilities	0.03	-	-	-	-
Total Current Liabilities	8.67	8.13	6.79	6.53	15.1
Long-Term Debt	-	-	0.12	-	0.16
Long-Term Leases	3.94	3.92	4.13	4.97	5.49
Long-Term Unearned Revenue	0.2	0.19	0.13	0.29	0.26
Long-Term Deferred Tax Liabilities	0.7	0.71	0.78	0.84	0.9
Other Long-Term Liabilities	0.39	0.66	1.41	-	-
Total Liabilities	13.9	13.61	13.35	12.62	21.92
Common Stock	7.83	7.83	7.59	7.53	4.53
Additional Paid-In Capital	0.51	0.51	0.51	0.35	0.35
Retained Earnings	-7.12	-7.25	-7.81	-5.82	-13.5
Comprehensive Income & Other	0.1	0.1	0.1	0.1	0.1
Shareholders' Equity	1.32	1.19	0.38	2.16	-8.52
Total Liabilities & Equity	15.22	14.8	13.74	14.78	13.41
Total Debt	6.73	6.55	6.1	6.99	18.12
Net Cash (Debt)	-3.79	-4.24	-4.34	-5.72	-17.11
Net Cash Per Share	-0.13	-0.15	-0.16	-0.20	-1.25
Filing Date Shares Outstanding	29.11	29.11	28.99	26.81	14.81
Total Common Shares Outstanding	29.11	29.11	27.45	26.81	14.81
Working Capital	-0.8	-0.68	-0.77	-1.53	-11.6
Book Value Per Share	0.05	0.04	0.01	0.08	-0.57
Tangible Book Value	-1.81	-1.99	-2.95	-1.38	-12.35
Tangible Book Value Per Share	-0.06	-0.07	-0.11	-0.05	-0.83
Machinery	0.54	0.54	0.48	0.48	0.47
Leasehold Improvements	1.26	1.25	1.18	1.18	0.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.